| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 121.87B | 125.45B | 115.11B | 113.51B | 107.85B | 98.15B |
| Gross Profit | 61.71B | 58.94B | 53.30B | 50.19B | 47.69B | 42.67B |
| EBITDA | 10.33B | 11.04B | 9.59B | 8.51B | 6.47B | 3.67B |
| Net Income | 5.64B | 3.71B | 3.48B | 2.78B | 1.89B | -775.00M |
Balance Sheet | ||||||
| Total Assets | 123.73B | 124.75B | 115.86B | 116.59B | 119.30B | 120.08B |
| Cash, Cash Equivalents and Short-Term Investments | 4.91B | 4.66B | 2.59B | 3.73B | 3.24B | 4.10B |
| Total Debt | 6.03B | 2.19B | 4.81B | 6.27B | 12.86B | 17.43B |
| Total Liabilities | 80.40B | 78.92B | 77.28B | 79.27B | 84.71B | 86.77B |
| Stockholders Equity | 43.33B | 45.83B | 38.58B | 37.32B | 34.59B | 33.31B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 11.10B | 2.79B | 7.06B | 4.91B | -141.00M |
| Operating Cash Flow | 0.00 | 15.23B | 6.73B | 10.17B | 7.56B | 2.50B |
| Investing Cash Flow | 0.00 | -12.49B | -3.90B | -2.19B | -3.02B | -3.30B |
| Financing Cash Flow | 0.00 | -669.00M | -3.97B | -7.49B | -5.40B | -715.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥1.05T | 9.13 | 9.37% | 2.59% | -1.40% | -14.78% | |
69 Neutral | ¥66.78B | 19.44 | ― | 1.09% | 8.99% | 4.49% | |
69 Neutral | ¥614.08B | 22.85 | 7.58% | 2.58% | 0.73% | -29.55% | |
66 Neutral | ¥285.14B | 2.68 | 4.97% | 2.01% | 0.87% | -38.26% | |
65 Neutral | ¥1.02T | 14.50 | 9.25% | 1.48% | -3.73% | 8.13% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | ¥551.74B | -72.11 | 9.06% | 1.84% | -1.23% | -121.69% |